全面洞察绿色合成方法,结构活动关系和Pyrazolic Chalcone衍生物的治疗潜力
Samyak Bajaj1, Akanksha Gupta1, Priyanshu Nema1
1Integrated Drug Discovery Research Laboratory, Department of Pharmaceutical Sciences, Dr. Harisingh Gour University (A Central University), Sagar (MP), India.
Mini reviews in medicinal chemistry
|November 8, 2024
概括
皮拉索基石灰石显示出治疗炎症,感染和癌症的前景. 本综述强调了它们的合成,比较了传统方法与环保绿色化学方法的药物发现方法.
科学领域:
- 药用化学 医学化学
- 有机合成 有机合成
- 药物发现 药物发现 药物发现
背景情况:
- 酸石具有广泛的治疗潜力,包括抗炎,抗氧化,抗微生物,抗瘤和抗糖尿病活动.
- 结构活动关系 (SAR) 研究对于理解它们的生物机制和设计改进的衍生品至关重要.
- 开发新的Pyrazolic chalcone衍生物对于推进治疗应用至关重要.
研究的目的:
- 审查pyrazolic chalcone衍生物及其治疗应用.
- 为了比较Pyrazolic chalcones的传统和绿色合成方法.
- 强调SAR研究在优化这些化合物的重要性.
主要方法:
- 皮拉酸合成和应用的文献综述.
- 传统化学合成与绿色合成方法的比较分析.
- 讨论 SAR 相关的原则,以优化pyrazolic chalcone.
主要成果:
- 皮拉索石在各种疾病模型中显示出显著的治疗潜力.
- 绿色合成方法为传统技术提供了可持续和环保的替代方案.
- SAR研究提供了一个框架,用于合理设计强效和安全的pyrazolic chalcone类似物.
结论:
- 皮拉酸衍生物是药物开发的一个有前途的化合物类别.
- 绿色合成策略对于可持续生产这些有价值的分子至关重要.
- 以SAR为指导的进一步研究将释放pyrazolic chalcones的全部治疗潜力.
相关概念视频
Structure-Activity Relationships and Drug Design
597
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
597
Prochirality
3.8K
The concept of prochirality leads to the nomenclature of the individual faces of a molecule and plays a crucial role in the enantioselective reaction. It is a concept where two or more achiral molecules react to produce chiral products. A typical process is the reaction of an achiral ketone to generate a chiral alcohol. Here, the achiral reactant reacts with an achiral reducing agent, sodium borohydride, to generate an equimolar mixture of the chiral enantiomers of the product. For example, an...
3.8K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.1K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.1K


